Winner Medical Co. Ltd. Class A

Winner Medical Co. Ltd. Class A

SSZSE:300888
29.46
CNY
-0.20
(-0.67%)
1.41EPS
21.95P/E
17.05BMarket Cap
Apr 28Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.47
2.93
3.54
4.95
6.78
7.36
8.67
23.03
13.48
19.19
13.82
15.36
18.82
19.29
Basic EPS, GAAP
0.17
0.25
0.43
0.79
0.83
0.81
1.04
7
2.08
2.79
0.98
1.19
1.32
1.33
Free Cash Flow per Basic Share
- -
- -
- -
- -
-0.33
-0.33
0.29
7.71
0.22
3.02
0.52
0.62
1.75
- -
Dividend per Share
0.1
0.09
0.12
0.11
0.22
0.11
0.11
0.19
1.29
0.68
1.39
0.71
1.04
0.82
Book Value per Share
1.44
2.21
2.54
3.2
3.83
5.04
6
17.41
17.88
19.63
19.4
19.15
19.78
19.55
Tangible Book Value per Share
1.33
2.1
2.39
3.06
3.58
4.79
5.75
17.06
17.43
16.15
16.28
15.12
16.22
15.84
Basic Weighted Avg Shares
515
515
515
517
516
522
527
544
596
592
592
584
582
583
Sales/Revenue/Turnover
1,272
1,510
1,819
2,560
3,498
3,839
4,575
12,534
8,037
11,351
8,185
8,978
10,949
11,248
Operating Margin (%)
9.33
11.73
14.87
19.68
16.09
13.9
13.93
39.84
16.23
19.32
11.47
10.85
11.93
11.79
Depreciation Expense
- -
- -
- -
- -
80
94
103
159
377
482
540
578
663
- -
Net Income, GAAP
88
129
221
410
427
425
546
3,810
1,239
1,651
580
695
768
777
Effective Tax Rate (%)
12.06
16.6
16.16
18.28
17.28
14.98
14.29
15.1
15.4
12.77
16.18
18.46
22.3
18.92
Profit Margin (%)
6.93
8.55
12.12
16
12.21
11.06
11.94
30.4
15.42
14.54
7.09
7.75
7.01
6.91
Working Capital
193
533
485
570
366
683
1,487
8,363
8,271
6,638
6,285
2,810
3,597
4,580
LT Debt
- -
- -
- -
- -
- -
5
134
364
382
326
462
494
467
704
Total Equity
742
1,142
1,310
1,653
1,978
2,661
3,164
10,408
10,687
12,198
12,110
11,876
12,293
12,212
Return on Invested Capital (%)
- -
11.08
15.86
25.8
20.68
15.72
17.15
51.48
10.92
12.94
4.63
5.13
5.6
5.48
Return on Capital (%)
- -
12.35
15.85
26.91
21.81
16.85
17.74
52.27
11.3
12.7
3.99
4.79
5.18
5.05
Return on Common Equity (%)
- -
13.72
18.02
27.69
23.56
18.34
18.78
56.22
11.76
14.74
4.99
6.13
6.78
6.78

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2,239
2,420
2,369
LT Borrowings
70
158
335
LT Finance Leases
393
376
369
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
582
583
583
Market Capitalization
19,229
16,317
17,052

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
8,734
9,686
9,765
Cash, Cash Equivalents & STI
4,195
5,055
5,124
Accounts Receivable, Net
1,161
1,122
1,220
Inventories
2,080
2,127
2,353
Total Current Liabilities
4,692
5,142
5,185
Payables & Accruals
- -
- -
- -
ST Debt
2,239
2,420
2,369
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
34.59%
3.53%
3.51%
Free Cash Flow
- -
261.25%
178.94%
Net Income, GAAP
64.67%
-13.77%
10.44%
Sales/Revenue/Turnover
28.94%
1.82%
21.96%
Total Cash Common Dividend
82.92%
141.01%
47.05%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,909
2,124
2,037
2,908
8,978
2025
2,605
2,691
- -
3,052
10,949
2026
2,679
2,807
2,710
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.31
0.35
0.29
0.24
1.19
2025
0.43
0.42
- -
0.06
1.32
2026
0.43
0.45
0.39
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.16
0.45
0.09
0.71
2025
0.11
0.28
- -
0.35
1.04
2026
0.01
0.1
0.36
- -
- -

Company Description

CEO
Jian Quan Li
Full Time Employees
15,855
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Building 2, Huilong Business Center Shenzhen GD China 518131
IPO Date
Sep 17, 2020
Business
Winner Medical Co., Ltd. (300888.SZ) manufactures and markets disposable medical consumables, wound care products, operating room solutions, and consumer health goods centered on cotton-based technologies in China and internationally. The company produces wound care items including traditional dressings such as gauze swabs, lap sponges, and bandages; advanced solutions like foam dressings, silicone foam dressings, super absorbent pads, collagen dressings, antimicrobial products, scar repair treatments, and compression therapies; as well as liquid skin protectants, debridement aids, and exudate management products; operating room supplies encompassing masks, gloves, protective apparel, surgical gowns and drapes, specialty packs, general surgical kits and trays, disinfection products, anesthesia kits, and catheter sets; and consumer offerings such as adult diapers, incontinence pads, cotton balls and swabs, foot care products, hand sanitizers, facial and lens cleansing wipes, sports hygiene items, wet and dry cotton towels, sanitary napkins, baby clothing, and cosmetic cotton products, marketed under the Winner Medical, Purcotton, and PureH2B brands for hospitals, pharmacies, personal protective equipment users, consumers, and industrial applications. Winner Medical operates production facilities in China, with products sold in multiple countries, and maintains a subsidiary relationship with Winner Group Limited. Founded in 1991 and headquartered in Shenzhen's Longhua District, the company listed on the Shenzhen Stock Exchange's A-share market in September 2020. In September 2024, Winner Medical completed its first international equity acquisition by purchasing a 75.2% stake in U.S.-based Global Resources International Inc. (GRI) for approximately $120 million, enhancing its global supply chain resilience, expanding product lines in surgical kits, drapes, gowns, and industrial protective clothing, and establishing operations in the United States and Europe.